Home » CSR in India » Glenmark bags ‘India Pharma Innovation of Year’ Award from Govt of India

CSR in India

Glenmark bags ‘India Pharma Innovation of Year’ Award from Govt of India

India Pharma Innovation of Year

Glenmark wins ‘India Pharma Innovation of the Year’ Award

Glenmark Pharmaceuticals Ltd. (Glenmark), a global pharmaceutical firm focused on innovation, was named runner-up in the ‘India Pharma Innovation of Year’ category and awarded the ‘India Pharma CSR of the Year’ award as part of the India Pharma & India Medical Device Awards 2022. The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Federation of Indian Chambers of Commerce and Industry (FICCI), and Invest India collaborated on the seventh edition of the annual awards. 
 
Glenmark’s various patents and advancements in its main therapy areas of Dermatology, Respiratory, and Oncology during the last three years have been recognized with this honor. It also recognizes the Company’s commitment to the healthcare industry, which includes fulfilling both immediate and long-term patient needs.

India Pharma Innovation of Year

Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals, commented on the distinction, saying, “Our goal has always been to produce holistically revolutionary medications for India and the rest of the world. We are honored to win the award, which underlines our dedication to developing new medications to address unmet medical needs. The prominence provided by these prizes will provide the Indian pharmaceutical sector a boost in terms of research and development.” 
 
Glenmark has previously received the Department of Pharmaceuticals’ India Pharma Leader Award (2015), Company of the Year (2016), Corporate Social Responsibility Program of the Year (2017), and ‘Indian Pharma Innovation of the Year’ honors (2021). 

Read more CSR India news on India Frontline.